Literature DB >> 17724556

Life habits in myotonic dystrophy type 1.

Cynthia Gagnon1, Jean Mathieu, Luc Noreau.   

Abstract

OBJECTIVE: To describe and compare life habits between individuals with adult and mild phenotypes of myotonic dystrophy; identify life habit dimensions in which accomplishment is compromised; and describe satisfaction related to life habits.
DESIGN: Cross-sectional study.
SUBJECTS: A random sample of 200 subjects with myotonic dystrophy (42 mild phenotypes, 158 adult phenotypes). MEASUREMENT: The Assessment of Life Habits (LIFE-H), a questionnaire assessing self-perceived life habits (activities and participation as described in the International Classification of Functioning, Disability and Health (ICF)).
RESULTS: Participants with the adult phenotype demonstrated significantly lower participation levels than those with the mild phenotype on 8 out of the 11 categories of the LIFE-H. Lower levels of accomplishment were reported in Mobility, Housing, Fitness, Nutrition, Personal Care, Employment, Recreation, and Community Life categories among the adult phenotype. The Recreation category was the most affected, with 4 out of 7 items revealing compromised accomplishment among 22-27% of individuals. The lowest satisfaction score was observed in the Employment and Recreation categories. In all categories, individuals with the adult phenotype displayed significantly lower satisfaction levels than those with the mild phenotype.
CONCLUSION: This study helped to establish a clearer distinction between activities and participation levels of individuals with the mild phenotype and those with the adult phenotype and supported tailored rehabilitation and community services to improve accomplishment of life habits.

Entities:  

Mesh:

Year:  2007        PMID: 17724556     DOI: 10.2340/16501977-0091

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  8 in total

Review 1.  Daytime sleepiness and myotonic dystrophy.

Authors:  Luc Laberge; Cynthia Gagnon; Yves Dauvilliers
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

2.  Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.

Authors:  Bryan P Fitzgerald; Kelly M Conn; Joanne Smith; Andrew Walker; Amy L Parkhill; James E Hilbert; Elizabeth A Luebbe; Richard T Moxley
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

3.  Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.

Authors:  Aymeric Ravel-Chapuis; Ali Al-Rewashdy; Guy Bélanger; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

4.  A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Émilie Petitclerc; Marie Kierkegaard; Jean Mathieu; Élise Duchesne; Luc J Hébert
Journal:  J Neurol       Date:  2018-05-21       Impact factor: 4.849

Review 5.  Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic Dystrophies.

Authors:  A Romigi; M Albanese; C Liguori; F Placidi; M G Marciani; R Massa
Journal:  J Neurodegener Dis       Date:  2013-11-04

6.  The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research.

Authors:  Libby Wood; Isabell Cordts; Antonio Atalaia; Chiara Marini-Bettolo; Paul Maddison; Margaret Phillips; Mark Roberts; Mark Rogers; Simon Hammans; Volker Straub; Richard Petty; Richard Orrell; Darren G Monckton; Nikoletta Nikolenko; Aura Cecilia Jimenez-Moreno; Rachel Thompson; David Hilton-Jones; Chris Turner; Hanns Lochmüller
Journal:  J Neurol       Date:  2017-04-10       Impact factor: 4.849

7.  DMPK gene DNA methylation levels are associated with muscular and respiratory profiles in DM1.

Authors:  Cécilia Légaré; Gayle Overend; Simon-Pierre Guay; Darren G Monckton; Jean Mathieu; Cynthia Gagnon; Luigi Bouchard
Journal:  Neurol Genet       Date:  2019-05-23

8.  Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease.

Authors:  Libby Wood; Guillaume Bassez; Corinne Bleyenheuft; Craig Campbell; Louise Cossette; Aura Cecilia Jimenez-Moreno; Yi Dai; Hugh Dawkins; Jorge Alberto Diaz Manera; Celine Dogan; Rasha El Sherif; Barbara Fossati; Caroline Graham; James Hilbert; Kristinia Kastreva; En Kimura; Lawrence Korngut; Anna Kostera-Pruszczyk; Christopher Lindberg; Bjorn Lindvall; Elizabeth Luebbe; Anna Lusakowska; Radim Mazanec; Giovani Meola; Liannna Orlando; Masanori P Takahashi; Stojan Peric; Jack Puymirat; Vidosava Rakocevic-Stojanovic; Miriam Rodrigues; Richard Roxburgh; Benedikt Schoser; Sonia Segovia; Andriy Shatillo; Simone Thiele; Ivailo Tournev; Baziel van Engelen; Stanislav Vohanka; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2018-09-05       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.